Serum concentrations of 25-hydroxyvitamin D and immunoglobulins in an older Swiss cohort: results of the Senior Labor Study

BMC Medicine

Lorenz Risch¹  Martin Risch³  Urs E Nydegger⁴  Pedro Medina⁴  Zeno Stanga⁵  Cristina Nock²  Benjamin Sakem⁴ 

[1]Division of Clinical Biochemistry Medical University Innsbruck, Innsbruck, Austria

[2]Private Medical Office, Grundgasse 2, CH-6460, Altdorf, Switzerland

[3]Central Laboratory, Kantonsspital Graubünden, Chur, Switzerland

[4]Division of Clinical Chemistry, Labormedizinisches Zentrum Dr. Risch, Waldeggstrasse 37, CH-3097, Liebefeld bei Bern, Switzerland

[5]Division of General Internal Medicine, University Hospital, Bern, Switzerland

关键词: Older people;    Sunlight exposure;    Humoral immunity;    Complement;    IgA;    Immunoglobulins;    25(OH)D;   

Others  :  856947
DOI  :  10.1186/1741-7015-11-176

 received in 2013-04-19, accepted in 2013-07-22,  发布年份 2013

【 摘 要 】

Background

Vitamin D and the components of humoral immunity play important roles in human health. Older people have lower 25-hydroxyvitamin D (25(OH)D) serum levels than younger adults. We aimed to determine the levels of 25(OH)D serum concentrations in healthy senior citizens and to study their relationship to the levels of components of humoral immunity.

Methods

A total of 1,470 healthy Swiss men and women, 60 years or older, were recruited for this study. A total of 179 subjects dropped out of the study because of elevated serum concentrations of C-reactive protein. Fasting blood sera were analyzed for 25(OH)D with the high-performance liquid chromatography (HPLC) and for parathyroid hormone (PTH), immunoglobulins and complement C4 and C3 concentrations with immunoassays. The percentage of participants in each of the four 25(OH)D deficiency groups - severely deficient (<10 ng/ml), deficient (10 to 20), insufficient (21 to 29 ng/ml) and normal (>=30 ng/ml) - were statistically compared. The relationship of the major components of the humoral system and age with 25(OH)D levels was also assessed.

Results

About 66% of the subjects had insufficient levels of 25(OH)D. Normal levels of 25(OH)D were found in 26.1% of the subjects of which 21% were males and 30.5% were females (total study population). Severely deficient levels of 25(OH)D were found in 7.98% of the total study population. Low levels of 25(OH)D were positively associated with IgG2 (P = 0.01) and with C4 (P = 0.02), yet were inversely related to levels of IgG1 and IgA (P < 0.05) and C3 (P = 0.01). Serum levels of total IgA, IgG, IgG2 and IgG4 peaked together with 25(OH)D during late summer.

Conclusions

Approximately two-thirds of the healthy, older Swiss population presented with Vitamin D insufficiency. The incremental shift in IgA and C3 levels might not necessarily reflect a deranged humoral immune defense; however, given the high prevalence of vitamin D deficiency, the importance of this condition in humoral immunity will be worth looking at more closely. This study supports the role of vitamin D in the competent immune system.

【 授权许可】

   
2013 Sakem et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Holick MF: The D-lemma: to screen or not to screen for 25-hydroxyvitamin D concentrations. Clin Chem 2010, 56:729-731.
• [2]Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM: Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab 2012, 97:1153-1158.
• [3]Beard JA, Bearden A, Striker R: Vitamin D and the anti-viral state. J Clin Virol 2011, 50:194-200.
• [4]Hajas A, Sandor J, Csathy L, Csipo I, Barath S, Paragh G, Seres I, Szegedi G, Shoenfeld Y, Bodolay E: Vitamin D insufficiency in a large MCTD population. Autoimmun Rev 2011, 10:317-324.
• [5]Messa P, Alfieri C, Rastaldi MP: Recent insights into vitamin D and its receptor. J Nephrol 2011, 24:S30-S37.
• [6]Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE: Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007, 179:1634-1647.
• [7]Luderer HF, Demay MB: The vitamin D receptor, the skin and stem cells. J Steroid Biochem Mol Biol 2010, 121:314-316.
• [8]Barchetta I, Carotti S, Labbadia G, Vespasiani GU, Onetti MA, Angelico F, Silecchia G, Leonetti F, Fraioli A, Picardi A, Morini S, Cavallo MG: Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. Hepatology 2012, 56:2180-2187.
• [9]Mora JR, Iwata M, von Andrian UH: Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008, 8:685-698.
• [10]Lemire JM, Adams JS, Sakai R, Jordan SC: 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1984, 74:657-661.
• [11]Bikle DD: Vitamin D and immune function: understanding common pathways. Curr Osteoporos Rep 2009, 7:58-63.
• [12]Enioutina EY, Bareyan D, Daynes RA: TLR-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses. J Immunol 2009, 182:4296-4305.
• [13]Hewison M: Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol 2010, 321:103-111.
• [14]Wimalawansa SJ: Vitamin D in the new millennium. Curr Osteoporos Rep 2012, 10:4-15.
• [15]Pincikova T, Nilsson K, Moen IE, Karpati F, Fluge G, Hollsing A, Knudsen PK, Lindblad A, Mared L, Pressler T, Hjelte L: Inverse relation between vitamin D and serum total immunoglobulin G in the Scandinavian Cystic Fibrosis Nutritional Study. Eur J Clin Nutr 2011, 65:102-109.
• [16]Kennel KA, Drake MT, Hurley DL: Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc 2010, 85:752-758.
• [17]Ginde AA, Liu MC, Camargo CA: Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Intern Med 2009, 169:626-632.
• [18]Rosen CJ: Clinical practice. Vitamin D insufficiency. N Engl J Med 2011, 364:248-254.
• [19]Alvarez-Rodriguez L, Lopez-Hoyos M, Garcia-Unzueta M, Amado JA, Cacho PM, Martinez-Taboada VM: Age and low levels of circulating vitamin D are associated with impaired innate immune function. J Leukoc Biol 2012, 91:829-838.
• [20]Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ: Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003, 77:204-210.
• [21]Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K: Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007, 167:1159-1165.
• [22]Pérez-López FR, Fernández-Alonso AM, Mannella P, Chedraui P: Vitamin D, sunlight and longevity. Minerva Endocrinol 2011, 36:257-266.
• [23]Schilling S: [Epidemic vitamin D deficiency among patients in an elderly care rehabilitation facility]. Dtsch Arztebl Int 2012, 109:33-38.
• [24]Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011, 96:1911-1930.
• [25]Lapid MI, Cha SS, Takahashi PY: Vitamin D and depression in geriatric primary care patients. Clin Inter Aging 2013, 8:509-514.
• [26]Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, Flicker L, Wark J, Jackson RD, Cauley JA, Meyer HE, Pfeifer M, Sanders KM, Stähelin HB, Theiler R, Dawson-Hughes B: A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 2012, 367:40-49. Erratum in: N Engl J Med 2012, 367:481. Oray, Endel J [corrected to Orav, Endel J]
• [27]Donkena KV, Young CY: Vitamin d, sunlight and prostate cancer risk. Adv Prev Med 2011, 2011:281863.
• [28]McGreevy C, Williams D: New insights about vitamin D and cardiovascular disease: a narrative review. Ann Intern Med 2011, 155:820-826.
• [29]Chadha MK, Fakih M, Muindi J, Tian L, Mashtare T, Johnson CS, Trump D: Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients. Prostate 2011, 71:368-372.
• [30]Zitt E, Sprenger-Maehr H, Knoll F, Neyer U, Lhotta K: Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease. Vaccine 2012, 30:931-935.
• [31]Elamin MB, Abu Elnour NO, Elamin KB, Fatourechi MM, Alkatib AA, Almandoz JP, Liu H, Lane MA, Mullan RJ, Hazem A, Erwin PJ, Hensrud DD, Murad MH, Montori VM: Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011, 96:1931-1942.
• [32]Lippi G, Montagnana M, Meschi T, Borghi L: Vitamin D concentration and deficiency across different ages and genders. Aging Clin Exp Res 2012, 24:548-551.
• [33]Orwoll E: Vitamin D deficiency in older men. J Clin Endocrinol Metab 2009, 94:1244.
• [34]Giallauria F, Milaneschi Y, Tanaka T, Maggio M, Canepa M, Elango P, Vigorito C, Lakatta EG, Ferrucci L, Strait J: Arterial stiffness and vitamin D levels: the Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2012, 97:3717-3723.
• [35]Farrell CJ, Martin S, McWhinney B, Straub I, Williams P, Herrmann M: State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem 2012, 58:531-542.
• [36]Holick MF: Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
• [37]Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Manson JE, Mayne ST, Ross AC, Shapses SA, Taylor CL: IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab 2012, 97:1146-1152.
• [38]Oren Y, Shapira Y, Agmon-Levin N, Kivity S, Zafrir Y, Altman A, Lerner A, Shoenfeld Y: Vitamin D insufficiency in a sunny environment: a demographic and seasonal analysis. Isr Med Assoc J 2010, 12:751-756.
• [39]Ademokun A, Wu YC, Martin V, Mitra R, Saöck U, Baxendale H, Kipling D, Dunn-Walters DK: Vaccination-induced changes in human B-cell repertoire and pneumococcal IgM and IgA antibody at different ages. Aging Cell 2011, 10:922-930.
• [40]Frasca D, Diaz A, Romero M, Mendez NV, Landin AM, Blomberg BB: Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011–2012 influenza vaccine season. Immun Ageing 2013, 10:14. BioMed Central Full Text
• [41]Burkhalter F, Schaub S, Dickenmann M: Preserved circannual rhythm of vitamin D in kidney transplant patients. Swiss Med Wkly 2012, 142:w13672.
• [42]Martineau AR, Nhamoyebonde S, Oni T, Rangaka MX, Marais S, Bangani N, Tsekela R, Bashe L, de Azevedo V, Caldwell J, Venton TR, Timms PM, Wilkinson KA, Wilkinson RJ: Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci U S A 2011, 108:19013-19017.
• [43]Stein EM, Shane E: Vitamin D in organ transplantation. Osteoporos Int 2011, 22:2107-2118.
• [44]Christakos S, Hewison M, Gardner DG, Wagner CL, Sergeev IN, Rutten E, Pittas AG, Boland R, Ferrucci L: Vitamin D beyond bone. Ann N Y Acad Sci 2013, 1287:45-58.
• [45]Lalor MK, Floyd S, Goark-Stlinska P, Weir RE, Blitz R, Bransion K, Fine PE, Dockrell HM: BCG vaccination: a role for vitamin D? PLoS One 2011, 6:e16709.
• [46]Ovsyannikova IG, Dhiman N, Haralambieva IH, Vierkant RA, O’Byrne MM, Jacobson RM, Poland GA: Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the toll-like vitamin A and D receptors, and innate immune response genes. Hum Genet 2009, 127:207-221.
• [47]Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, Soler D, Butcher EC: DCs metabolize sunlight-induced vitamin D3 to ‘program’ T cell attraction to the epidermal chemokine CCL27. Nat Immunol 2007, 8:285-293.
• [48]Edfeldt K, Liu PT, Chun R, Fabri M, Schenk M, Wheelwright M, Keegan C, Krutzik SR, Adams JS, Hewison M, Modlin RL: T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci U S A 2010, 107:22593-22598.
• [49]Chen Y, Liu W, Sun T, Huang Y, Wang Y, Deb DK, Yoon D, Kong J, Thadhani R, Li YC: 1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages. J Immunol 2013, 190:3687-3695.
• [50]Liu PT, Wheelwright M, Teles R, Komisopoulou E, Edfeldt K, Ferguson B, Mehta MD, Vazirnia A, Rea TH, Sarno EN, Graeber TG, Modlin RL: MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat Med 2012, 18:267-273.
• [51]Hustmyer FG, Girasole G, Manolagas SC: Signal-dependent pleiotropic regulation of lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3: potent modulation of the hormonal effects by phorbol esters. Immunology 1992, 77:520-526.
• [52]Holmoy T, Lossius A, Gundersen TE, Moen SM, Castellazzi M, Fainardi E, Casetta I: Intrathecal levels of vitamin D and IgG in multiple sclerosis. Acta Neurol Scand 2012, 125:e28-e31.